Continuous Renal Replacement Therapy (CRRT) Market 2021 Global Scope by Product, Modality, Patient, Growth Rate, CAGR and Key Players Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan)

This Continuous Renal Replacement Therapy (CRRT) Market report is generated with the combination of best industry insight, practical solutions, talent solutions, and the latest technology. It gives an explanation about a methodical investigation of the existing scenario of the global market, which takes into account several market dynamics. With the market data of this industry analysis report, emerging trends along with major drivers, challenges, and opportunities in the market for the Medical Devices industry can be identified and analyzed. Excellent practice models and methods of research utilized while generating this market document reveals the best opportunities to thrive in the market. While generating this Continuous Renal Replacement Therapy (CRRT) Market report, markets on the local, regional as well as global level are explored.

Request for FREE Sample Report: To Know the Impact of COVID-19 on this Industry @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=431306

The global continuous renal replacement therapy market size is projected to reach USD 1.7 billion by 2026 from USD 1.2 billion in 2021, at a CAGR of 7.3% during the forecast period. Continuous Renal Replacement Therapy (CRRT) Market by Product (Disposables (Hemofilters, Bloodlines), Machine, Dialysates, Renal Replacement fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF), Patient (Adult, Pediatrics, Neonates) - Global Forecasts to 2026

The major players operating in the continuous renal replacement therapy market are

Baxter International Inc. (US),
Fresenius Medical Care AG & Co. KGaA (Germany),
NIKKISO CO., LTD. (Japan),
B. Braun Melsungen AG (Germany),
Asahi Kasei Corporation (Japan),
Toray Medical Co., Ltd. (Japan),
Infomed SA (Switzerland),
Medtronic plc (Ireland),
Medica S.p.A. (Italy),
Medical Components, Inc. (US),
Medites Pharma spol. s.r.o. (Czech Republic),
SWS Hemodialysis Care Co., Ltd. (China),
Ningbo Tianyi Medical Devices Co., Ltd. (China),
Nipro Corporation (Japan),
and Anjue Medical Equipment Co., Ltd. (China),

The recent COVID-19 global pandemic has also impacted the continuous renal replacement therapy market. The surge in the number of COVID cases, along with the rise in its severity rate, is likely to create a potential increase in the incidence of kidney damage. This makes AKI the next emerging healthcare concern after respiratory tract infections among patients with COVID-19.Due to the pandemic, the demand for renal replacement fluids has increased significantly worldwide. The demand for RRT among patients with COVID-19 has increased fivefold in comparison to the historical US populations (4.9% as of 2020 VS. 0.9% earlier) (Source: American Society of Nephrology, 2021). According to an article published by the International Society of Nephrology 2020, countries such as China and Italy reported AKI rates as high as 29%. The early initiation of continuous renal replacement therapy (CRRT) is an important step to curbing the rising incidence of AKI due to the COVID-19 infection. However, owing to the rapid rise in the demand by healthcare systems, HD and PD exist as an alternative dialysis treatment in ICUs, which can have a negative impact on the growth of the CRRT market during this period.

Research Coverage

This report studies the continuous renal replacement therapy market based on the product, modality, age group and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the continuous renal replacement therapy market, and high-growth regions and their drivers, restraints, opportunities, and challenges. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

Enquire Here for, Report Enquiry, Discount and Customization @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=431306

“The dialysate and replacement fluid segment to capture the largest share in continuous renal replacement therapymarket, by product, during the forecast period.”

Thedialysate and replacement fluidsegment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the significant rise in demand for CRRT in the treatment of hemodynamically unstable patients, the increased number of manufacturers offering dialysate and replacement fluids for renal replacement therapy, and the strong presence of players in the market.

“The CVVHDF segment to witness highest growth rate in continuous renal replacement therapy market, by modality in 2021.”

The CVVHDF modality segment is anticipated to witness the highest growth rate during the forecast period. The growing preference of CVVHDF modality among a nephrologist and critical care physician, and the advantages such as better clearance of medium-sized solutes as compared to hemodialysis (owing to the combination of hem filtration with the continuous HD procedure), proper acid-base balance without additional intervention, and a significant reduction in CRRT-related phosphate depletion area likely to play strong role in supporting the growth of the segment in the coming years.

“The Adults segment accounted for the largest share of the continuous renal replacement therapy, by age group, in 2021”

The rapidly growing cases of adult acute renal disease injury across the globe and the rising number of hospital admission among youth adults are playing a critical role in increasing the adoption of CRRT among adult age group population. Moreover, increasing frequency of aggressive surgical and medical interventions among adults, and the increasing the risk of developing AKI and further contributing to the market growth.

“The Asia Pacific market to grow at the highest CAGR during the forecast period.”

The continuous renal replacement therapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Increase in the awareness of continuous renal replacement therapy, increasing healthcare expenditures, increasing patient population, rising sepsis incidence, increasing prevalence of hypertension & diabetes (major causes of AKI), the high use of CRRT in Australia and Japan, improving healthcare expenditure on renal diseases, and increasing accessibility to CRRT for AKI treatment.

Breakdown of supply-side primary interviews:

By Company Type: Tier 1: 25%, Tier 2: 30%, and Tier 3: 45%
By Designation: C-level: 26%, D-level: 30%, and Others: 44%
By Region: North America: 40.4%, Europe: 28.0%, APAC: 19.0%, Latin America: 7.7%, and the Middle East & Africa: 5.0%

Table Of Contents

1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.2.1 Inclusions & Exclusions
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For The Study
1.4 Currency Used For The Study
1.5 Major Market Stakeholders
1.6 Summary Of Changes

2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
Figure 2 Breakdown Of Primaries: Continuous Renal Replacement Therapy Market
2.2 Market Estimation Methodology
Figure 3 Research Methodology: Hypothesis Building
2.2.1 Revenue Mapping-Based Market Estimation
2.2.2 Usage-Based Market Estimation
Figure 4 Estimation Of Crrt Procedures
Figure 5 Market Size Estimation: Continuous Renal Replacement Therapy Market Based On Product Utilization Methodology
Figure 6 Market Size Estimation: Continuous Renal Replacement Therapy Market Based On Revenue Mapping Methodology
2.2.3 Primary Research Validation
2.3 Data Triangulation
Figure 7 Data Triangulation Methodology
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary
Figure 8 Continuous Renal Replacement Therapy Market, By Product, 2021 Vs. 2026 (Usd Million)
Figure 9 Continuous Renal Replacement Therapy Market, By Modality, 2021 Vs. 2026 (Usd Million)
Figure 10 Continuous Renal Replacement Therapy Market, By Age Group, 2021 Vs. 2026 (Usd Million)
Figure 11 Geographical Snapshot Of The Continuous Renal Replacement Therapy Market

4 Premium Insights
4.1 Continuous Renal Replacement Therapy Market Overview
Figure 12 Rising Prevalence Of Aki And Growing Awareness About Crrt To Drive Market Growth
4.2 Continuous Renal Replacement Therapy Market Share, By Age Group, 2021
Figure 13 Adults Segment To Dominate The Continuous Renal Replacement Therapy Market In 2021
4.3 Asia Pacific: Continuous Renal Replacement Therapy Market, By Product And Country
Figure 14 Dialysates And Replacement Fluids Account For The Largest Share Of The Crrt Products Market In The Apac
Figure 15 Apac Market To Register The Highest Growth Rate During The Forecast Period (2021–2026)

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 16 Continuous Renal Replacement Therapy Market: Drivers, Restraints, Opportunities, And Challenges
5.2.1 Drivers
5.2.1.1 Increasing Incidence Of Acute Kidney Injury (Aki)
Figure 17 Global Incidence Of Aki, 2010 Vs. 2015 Vs. 2020
Table 1 Number Of People Aged 65 Years Or Over, By Region, 2019 Vs. 2050
5.2.1.2 Growing Number Of Icu Patients With Aki And Increasing Incidence Of Sepsis
Figure 18 Impact Of Icu-Acquired Aki In The Us
5.2.1.3 Increasing Clinical Advantage Of Crrt Over Intermittent Blood Purification
5.2.1.4 Technological Advancements And New Product Launches
5.2.1.5 Growing Prevalence Of Diabetes And Hypertension
Figure 19 Top 5 Countries With Children And Adolescents With Type I Diabetes, 2019
5.2.2 Restraints
5.2.2.1 Stringent Regulatory Guidelines In North America
5.2.2.2 High Procedural Cost Of Crrt
5.2.3 Opportunities
5.2.3.1 Emerging Markets In Apac And Row
5.2.3.2 Increasing Applications Of Crrt
5.2.3.2.1 Evolution Of Crrt From A Simple Renal Replacement Treatment To Multi-Organ Support Therapy
5.2.3.2.2 Progression Of Crrt From Adaptive Renal Devices To Multipurpose Treatment Machines
5.2.3.3 Ongoing Research To Establish The Safety And Efficacy Profile Of Crrt
5.2.3.4 Development Of Crrt Systems For Pediatric Patients
5.2.3.4.1 The Carpediem Project
5.2.3.5 Untapped Growth Opportunities In North America
5.2.4 Challenges
5.2.4.1 High Complexity Of Crrt
5.2.4.2 Lack Of Standard Treatment Guidelines In Developing Nations
5.2.4.3 Shortage Of Trained Icu Professionals In Developing Nations
5.2.4.4 Poor Reimbursement Scenario In Developing Countries
5.2.4.5 Lack Of Awareness About The Benefits Of Crrt
5.3 Global Regulatory Landscape
5.3.1 North America
5.3.2 Europe
5.3.3 Asia Pacific
5.3.3.1 India
5.3.3.2 China
5.3.3.3 Japan
5.3.3.4 South Korea
5.3.4 Rest Of The World (Row)
5.3.4.1 Brazil
5.3.4.2 Argentina
5.4 Global Reimbursement Scenario
5.4.1 North America
5.4.2 Europe
5.4.3 Asia Pacific
5.4.4 Japan
5.4.5 Rest Of The World (Row)
5.4.5.1 Brazil
5.4.5.2 Central America And The Caribbean
5.5 Covid-19 Impact On The Crrt Market
Figure 20 Us: Covid-19 Hospitalization Data For Specialized Medical Conditions In Adults (As Of April 11, 2020)
5.6 Value Chain Analysis
Figure 21 Value Chain Of The Continuous Renal Replacement Therapy Market
5.7 Ecosystem Coverage
5.8 Pricing Trend Analysis
Table 2 Average Price Of Crrt Systems And Consumables, By Country, 2020 (Usd)
5.9 Porter’s Five Forces Analysis
Table 3 Continuous Renal Replacement Therapy Market: Porter’s Five Forces Analysis
5.9.1 Threat From New Entrants
Figure 22 Threat From New Entrants
5.9.2 Threat From Substitutes
Figure 23 Threat From Substitutes
5.9.3 Bargaining Power Of Suppliers
Figure 24 Bargaining Power Of Suppliers
5.9.4 Bargaining Power Of Buyers
Figure 25 Bargaining Power Of Buyers
5.9.5 Intensity Of Competitive Rivalry
Figure 26 Intensity Of Competitive Rivalry

6 Global Continuous Renal Replacement Therapy Market, By Product
6.1 Introduction
Table 4 Continuous Renal Replacement Therapy Market, By Product, 2019–2026 (Usd Million)
6.2 Dialysates & Replacement Fluids
6.2.1 Rising Demand For Dialysates Has Supported Market Growth
Table 5 Dialysates & Replacement Fluids Market, By Modality, 2019–2026 (Usd Million)
Table 6 Dialysates & Replacement Fluids Market, By Age Group, 2019–2026 (Usd Million)
Table 7 Dialysates & Replacement Fluids Market, By Region, 2019–2026 (Usd Million)
6.3 Disposables
Table 8 Disposables Market, By Type, 2019–2026 (Usd Million)
Table 9 Disposables Market, By Modality, 2019–2026 (Usd Million)
Table 10 Disposables Market, By Age Group, 2019–2026 (Usd Million)
Table 11 Disposables Market, By Region, 2019–2026 (Usd Million)
6.3.1 Hemofilters
6.3.1.1 Hemofilters Are Widely Adopted During Crrt Procedures For The Treatment Of Aki
Table 12 Hemofilters Market, By Region, 2019–2026 (Usd Million)
Table 13 Hemofilters Market, By Modality, 2019–2026 (Usd Million)
Table 14 Hemofilters Market, By Age Group, 2019–2026 (Usd Million)
6.3.2 Bloodline Sets & Tubes
6.3.2.1 Established Players Are Focusing On Strengthening Their Bloodline Sets And Tubes Product Lines
Table 15 Bloodline Sets & Tubes Market, By Region, 2019–2026 (Usd Million)
Table 16 Bloodline Sets & Tubes Market, By Modality, 2019–2026 (Usd Million)
Table 17 Bloodline Sets & Tubes Market, By Age Group, 2019–2026 (Usd Million)
6.3.3 Other Disposables
Table 18 Other Disposables Market, By Region, 2019–2026 (Usd Million)
Table 19 Other Disposables Market, By Modality, 2019–2026 (Usd Million)
Table 20 Other Disposables Market, By Age Group, 2019–2026 (Usd Million)
6.4 Crrt Systems
6.4.1 Introduction Of Advanced Products To Drive The Demand For Crrt Systems
Table 21 Crrt Systems Market, By Modality, 2019–2026 (Usd Million)
Table 22 Crrt Systems Market, By Age Group, 2019–2026 (Usd Million)
Table 23 Crrt Systems Market By Region, 2019–2026 (Usd Million)

7 Global Continuous Renal Replacement Therapy Market, By Modality

Read More..................

Purchase the Report Directly @ https://www.reportsnreports.com/purchase.aspx?name=431306

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

This release was published on openPR.